Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease
10.1021/jm501722s
Saved in:
Main Authors: | Huleatt Paul B., Khoo Mui Ling, Chua Yi Yuan, Tan Tiong Wei, Liew Rou Shen, Balogh Balazs, Deme Ruth, Goloncser Flora, Magyar Kalman, Sheela David P., HO HAN KIAT, Sperlagh Beta, Matyus Peter, Chai Li Lin Christina |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
American Chemical Society
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/127507 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
MPTP and Monoamine oxidase B inhibitors
by: ลีณา ลีลาศวัฒนกิจ
Published: (2010) -
Clinical utility of neuroprotective agents in neurodegenerative diseases: Current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis
by: Dunkel, P., et al.
Published: (2014) -
Monoamine oxidase inhibitors for various psychiatric disorders and conditions
by: Penchaya Atiwannapat, et al.
Published: (2018) -
Membrane reconstitution of monoamine oxidase enzymes on supported lipid bilayers
by: Wang, Liulin, et al.
Published: (2020) -
Central monoamine oxidase and phenolsulfotransferase activities in spontaneously hypertensive rats
by: Sim, M.K.
Published: (2012)